HLS Therapeutics, Inc. (HLS.TO)
3.65
-0.19
(-4.95%)
CAD |
TSX |
Aug 26, 16:00
HLS Therapeutics Shareholders Equity (Quarterly) : 78.37M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 78.37M |
| March 31, 2026 | 81.74M |
| December 31, 2025 | 84.53M |
| September 30, 2025 | 85.90M |
| June 30, 2025 | 90.82M |
| March 31, 2025 | 96.14M |
| December 31, 2024 | 102.60M |
| September 30, 2024 | 107.17M |
| June 30, 2024 | 113.17M |
| March 31, 2024 | 120.53M |
| December 31, 2023 | 128.82M |
| September 30, 2023 | 137.64M |
| June 30, 2023 | 147.46M |
| March 31, 2023 | 160.90M |
| December 31, 2022 | 169.80M |
| September 30, 2022 | 180.61M |
| June 30, 2022 | 186.27M |
| March 31, 2022 | 198.64M |
| December 31, 2021 | 203.03M |
| September 30, 2021 | 208.65M |
| June 30, 2021 | 210.30M |
| March 31, 2021 | 210.47M |
| December 31, 2020 | 215.62M |
| September 30, 2020 | 225.53M |
| June 30, 2020 | 229.60M |
| Date | Value |
|---|---|
| March 31, 2020 | 241.25M |
| December 31, 2019 | 231.08M |
| September 30, 2019 | 249.63M |
| June 30, 2019 | 252.29M |
| March 31, 2019 | 209.69M |
| December 31, 2018 | 216.46M |
| September 30, 2018 | 215.69M |
| June 30, 2018 | 242.74M |
| March 31, 2018 | 244.60M |
| December 31, 2017 | |
| September 30, 2017 | 32.48M |
| June 30, 2017 | 32.88M |
| March 31, 2017 | 33.21M |
| December 31, 2016 | 33.56M |
| September 30, 2016 | 34.02M |
| June 30, 2016 | 34.33M |
| March 31, 2016 | 34.81M |
| December 31, 2015 | 36.12M |
| September 30, 2015 | 36.81M |
| June 30, 2015 | 52.29M |
| March 31, 2015 | 52.63M |
| December 31, 2014 | 54.27M |
| September 30, 2014 | 48.17M |
| June 30, 2014 | 45.60M |
| March 31, 2014 | 45.19M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Bausch Health Cos., Inc. | -2.513B |
| Cipher Pharmaceuticals, Inc. | 194.73M |
| BioSyent, Inc. | 45.84M |
| Revive Therapeutics Ltd. | -4.025M |
| Knight Therapeutics, Inc. | 798.59M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 182.38M |
| Total Liabilities (Quarterly) | 104.01M |
| Debt to Equity Ratio | 0.7586 |
| Current Ratio | 1.049 |
| Net Debt Paydown Yield | 4.68% |